While a diagnosis of cancer is still a serious medical issue, the disease is becoming overall less and less scary. Reports are showing a steady decline in the number of new cases and a significant decrease in cancer-related deaths, by approximately 23%.
The field of cancer research is more animated than ever. Testing has become simpler and more reliable, allowing for early detection. Treatment is now more diverse and can be better tailored for individual needs, increasing effectiveness. Chemotherapy relies on safer drugs, radiation is better targeted. Immunotherapy is showing effectiveness in a wide variety of cancers. These are all reasons to feel confident in overcoming the disease.
Breast cancer, for example, the most common type of malignancy affecting millions of women worldwide can be more easily managed with Neratinib (Nerlyx). This is a kinase inhibitor drug that considerably lowers the risk of relapse. In fact, thanks to the Trial Assigning Individualized Options for Treatment, or TAILORx, some patients can actually be spared having to go through chemotherapy, thus reducing exposure to cytotoxic agents and associated side effects.
There are currently more options for metastatic patients, including courses with Olaparib (also known as Lynparza). As a PARP inhibitor, the drug focuses on disrupting a tumor cell’s ability to repair itself, making them more susceptible to treatment.
Biological therapy is another emerging alternative. This is an approach that tries to boost the body’s natural defenses in order to fight cancer, by employing monoclonal antibodies, (CAR)T-cell therapies or various vaccines.
These are only a few of the more recent options used to increase patient care and improve general outcome.
Be strong and stay healthy!